Eva Munck‐Wikland

6.8k total citations · 2 hit papers
121 papers, 5.4k citations indexed

About

Eva Munck‐Wikland is a scholar working on Otorhinolaryngology, Cancer Research and Oncology. According to data from OpenAlex, Eva Munck‐Wikland has authored 121 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Otorhinolaryngology, 50 papers in Cancer Research and 47 papers in Oncology. Recurrent topics in Eva Munck‐Wikland's work include Head and Neck Cancer Studies (77 papers), Cancer-related molecular mechanisms research (43 papers) and Cancer-related Molecular Pathways (13 papers). Eva Munck‐Wikland is often cited by papers focused on Head and Neck Cancer Studies (77 papers), Cancer-related molecular mechanisms research (43 papers) and Cancer-related Molecular Pathways (13 papers). Eva Munck‐Wikland collaborates with scholars based in Sweden, United States and Finland. Eva Munck‐Wikland's co-authors include Tina Dalianis, Johan Lindholm, Torbjörn Ramqvist, Anders Näsman, Lalle Hammarstedt‐Nordenvall, Hanna Dahlstrand, David Lindquist, Linda Marklund, Hanna Mellin and Mircea Romanitan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Eva Munck‐Wikland

120 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral‐induced carcinoma?

2009 568 citations Anders Näsman, Per Attner et al. International Journal of Cancer profile →
Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer

1992 473 citations Eva Munck‐Wikland et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Munck‐Wikland Sweden	35	3.1k	2.1k	1.9k	1.2k	1.1k	121	5.4k
Kevin P. Redmond United States	11	4.2k 1.3×	2.4k 1.2×	1.9k 1.0×	642 0.5×	966 0.9×	27	5.4k
Rita Axelrod United States	21	4.3k 1.4×	2.6k 1.2×	2.5k 1.3×	738 0.6×	1.2k 1.1×	51	6.5k
Rebecca D. Chernock United States	36	2.2k 0.7×	1.9k 0.9×	1.4k 0.8×	440 0.4×	746 0.7×	117	3.9k
Anders Näsman Sweden	29	2.0k 0.6×	1.0k 0.5×	1.1k 0.6×	742 0.6×	662 0.6×	80	3.0k
Jacqueline E. van der Wal Netherlands	39	840 0.3×	1.5k 0.7×	1.3k 0.7×	455 0.4×	776 0.7×	87	3.8k
J. Guigay France	35	1.6k 0.5×	1.1k 0.5×	2.9k 1.6×	646 0.5×	1.1k 1.0×	176	4.8k
M. L. Gillison United States	7	1.9k 0.6×	1.2k 0.6×	893 0.5×	335 0.3×	470 0.4×	8	2.5k
Marianne Hamilton Therkildsen Denmark	30	978 0.3×	1.4k 0.7×	1.2k 0.6×	552 0.5×	761 0.7×	63	2.9k
Glenn J. Hanna United States	26	756 0.2×	522 0.2×	1.4k 0.7×	497 0.4×	591 0.5×	149	2.6k
Hanna Dahlstrand Sweden	17	1.4k 0.4×	761 0.4×	636 0.3×	495 0.4×	372 0.3×	35	2.0k

Countries citing papers authored by Eva Munck‐Wikland

Since Specialization

Citations

This map shows the geographic impact of Eva Munck‐Wikland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Munck‐Wikland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Munck‐Wikland more than expected).

Fields of papers citing papers by Eva Munck‐Wikland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Munck‐Wikland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Munck‐Wikland. The network helps show where Eva Munck‐Wikland may publish in the future.

Co-authorship network of co-authors of Eva Munck‐Wikland

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Munck‐Wikland. A scholar is included among the top collaborators of Eva Munck‐Wikland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Munck‐Wikland. Eva Munck‐Wikland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marklund, Linda, et al.. (2023). Regulatory B cells producing IL‐10 are increased in human tumor draining lymph nodes. International Journal of Cancer. 153(4). 854–866. 12 indexed citations

Sjöström, Mats, Eva Munck‐Wikland, Andreas Thor, et al.. (2022). Mandibular resection in patients with head and neck cancer: acute and long-term complications after reconstruction. Acta Oto-Laryngologica. 142(1). 78–83. 3 indexed citations

Marklund, Linda, et al.. (2022). Tumour-draining lymph nodes in head and neck cancer are characterized by accumulation of CTLA-4 and PD-1 expressing Treg cells. Translational Oncology. 23. 101469–101469. 14 indexed citations

Ährlund‐Richter, Andreas, Michael Mints, Anders Näsman, et al.. (2020). Immune related proteins and tumor infiltratingCD8+ lymphocytes in hypopharyngeal cancer in relation to human papillomavirus (HPV) and clinical outcome. Head & Neck. 42(11). 3206–3217. 8 indexed citations

Haapaniemi, Aaro, Lovisa Farnebo, Jussi Tarkkanen, et al.. (2017). WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer. Oncology Reports. 38(4). 2062–2068. 11 indexed citations

Chaturvedi, Anil K., Huan Song, Philip S. Rosenberg, et al.. (2016). Tonsillectomy and Incidence of Oropharyngeal Cancers. Cancer Epidemiology Biomarkers & Prevention. 25(6). 944–950. 23 indexed citations

Sivars, Lars, Cinzia Bersani, Nathalie Grün, et al.. (2016). Human papillomavirus is a favourable prognostic factor in cancer of unknown primary in the head and neck region and in hypopharyngeal cancer. Molecular and Clinical Oncology. 5(6). 671–674. 18 indexed citations

Mercke, Claes, et al.. (2015). Cancer of the gingiva. European Archives of Oto-Rhino-Laryngology. 273(6). 1335–1345. 12 indexed citations

Dalianis, Tina, Nathalie Grün, J. Koch, et al.. (2015). Human papillomavirus DNA and p16INK4a expression in hypopharyngeal cancer and in relation to clinical outcome, in Stockholm, Sweden. Oral Oncology. 51(9). 857–861. 34 indexed citations

10.

Nordfors, Cecilia, Nathalie Grün, Nikolaos Tertipis, et al.. (2013). CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. European Journal of Cancer. 49(11). 2522–2530. 164 indexed citations

11.

Johansson, Ann‐Charlotte, Fredrik Jerhammar, Maja Bradic Lindh, et al.. (2012). Cancer-Associated Fibroblasts Induce Matrix Metalloproteinase–Mediated Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cells. Molecular Cancer Research. 10(9). 1158–1168. 101 indexed citations

12.

Attner, Per, Anders Näsman, Juan Du, et al.. (2011). Survival in patients with human papillomavirus positive tonsillar cancer in relation to treatment. International Journal of Cancer. 131(5). 1124–1130. 19 indexed citations

13.

Wangsa, Darawalee, Michael Ryott, Fredrik Petersson, et al.. (2008). Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma. British Journal of Cancer. 99(7). 1121–1128. 61 indexed citations

14.

Tani, Edneia, et al.. (2004). Image Cytometry DNA‐Analysis of Fine Needle Aspiration Cytology to Aid Cytomorphology in the Distinction of Branchial Cleft Cyst from Cystic Metastasis of Squamous Cell Carcinoma: A Prospective Study. The Laryngoscope. 114(11). 1997–2000. 16 indexed citations

15.

Dahlgren, Liselotte, Hanna Dahlstrand, David Lindquist, et al.. (2004). Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. International Journal of Cancer. 112(6). 1015–1019. 150 indexed citations

16.

Strander, Hans, et al.. (2002). Low Levels of Endostatin in the Urine from Patients with Malignant Disease. Tumor Biology. 23(4). 222–227. 5 indexed citations

17.

Mellin, Hanna, Signe Friesland, Rolf Lewensohn, Tina Dalianis, & Eva Munck‐Wikland. (2000). Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival. International Journal of Cancer. 89(3). 300–304. 21 indexed citations

18.

Munck‐Wikland, Eva, et al.. (1994). Nuclear DNA content, proliferating‐cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. International Journal of Cancer. 56(1). 95–99. 46 indexed citations

19.

Munck‐Wikland, Eva, et al.. (1993). Proliferating cell nuclear antigen (PCNA) expression and nuclear DNA content in predicting recurrence after radiotherapy of early glottic cancer. European Journal of Cancer Part B Oral Oncology. 29(1). 75–79. 19 indexed citations

20.

Munck‐Wikland, Eva, Richard Kuylenstierna, Britta Wahrén, Johan Lindholm, & S. Haglund. (1988). Tumor markers carcinoembryonic antigen, CA 50, and CA 19-9 and squamous cell carcinoma of the esophagus pretreatment screening. Cancer. 62(11). 2281–2286. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact